CSL Limited (CSL.AX)
AUD 278.79
(-1.22%)
AUD 278.79
(-1.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 5.64 Billion AUD | -57.73% |
| 2023 | 4.36 Billion USD | 10.62% |
| 2022 | 3.94 Billion USD | -4.7% |
| 2021 | 4.13 Billion AUD | 4.0% |
| 2020 | 3.97 Billion AUD | 15.76% |
| 2019 | 3.43 Billion AUD | 14.16% |
| 2018 | 3 Billion AUD | 30.81% |
| 2017 | 2.3 Billion AUD | 35.92% |
| 2016 | 1.69 Billion AUD | -4.57% |
| 2015 | 1.77 Billion AUD | 39.34% |
| 2014 | 1.27 Billion AUD | 12.21% |
| 2013 | 1.13 Billion AUD | 24.0% |
| 2012 | 914.81 Million AUD | -6.2% |
| 2011 | 975.24 Million AUD | 7.26% |
| 2010 | 909.25 Million AUD | 32.72% |
| 2009 | 685.1 Million AUD | 16.76% |
| 2008 | 586.78 Million AUD | 26.79% |
| 2007 | 462.78 Million AUD | 1490.44% |
| 2006 | 29.09 Million AUD | -84.09% |
| 2005 | 182.85 Million AUD | 894.66% |
| 2004 | 18.38 Million AUD | -52.53% |
| 2003 | 38.72 Million AUD | -41.15% |
| 2002 | 65.8 Million AUD | 262.02% |
| 2001 | -40.61 Million AUD | -103.86% |
| 2000 | -19.92 Million AUD | -142.04% |
| 1999 | 47.39 Million AUD | 16.42% |
| 1998 | 40.71 Million AUD | -87.2% |
| 1997 | 318.09 Million AUD | 1476.26% |
| 1996 | -23.11 Million AUD | -20.96% |
| 1995 | -19.1 Million AUD | -153.71% |
| 1994 | -7.53 Million AUD | -5.21% |
| 1993 | -7.15 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 5.64 Billion AUD | 29.56% |
| 2024 Q4 | 1.71 Billion AUD | 0.0% |
| 2024 Q2 | 3.94 Billion AUD | 0.0% |
| 2023 Q4 | 1.22 Billion AUD | 0.0% |
| 2023 FY | 4.36 Billion USD | 10.62% |
| 2023 Q2 | 3.13 Billion AUD | 0.0% |
| 2022 FY | 3.94 Billion USD | -4.7% |
| 2022 Q2 | 2.98 Billion AUD | 0.0% |
| 2022 Q4 | 938.42 Million AUD | 0.0% |
| 2021 Q2 | 3.24 Billion AUD | 0.0% |
| 2021 Q4 | 962.75 Million AUD | 0.0% |
| 2021 FY | 4.13 Billion AUD | 4.0% |
| 2020 FY | 3.97 Billion AUD | 15.76% |
| 2020 Q4 | 1.62 Billion AUD | 0.0% |
| 2020 Q2 | 2.33 Billion AUD | 0.0% |
| 2019 Q4 | 1.32 Billion AUD | 0.0% |
| 2019 FY | 3.43 Billion AUD | 14.16% |
| 2018 FY | 3 Billion AUD | 30.81% |
| 2018 Q4 | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 FY | 2.3 Billion AUD | 35.92% |
| 2016 FY | 1.69 Billion AUD | -4.57% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | 1.77 Billion AUD | 39.34% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 FY | 1.27 Billion AUD | 12.21% |
| 2014 Q3 | 389.54 Million AUD | 0.0% |
| 2014 Q2 | 389.54 Million AUD | 8.17% |
| 2014 Q1 | 360.1 Million AUD | 0.0% |
| 2014 Q4 | - AUD | -100.0% |
| 2013 Q2 | 360.1 Million AUD | 35.2% |
| 2013 FY | 1.13 Billion AUD | 24.0% |
| 2013 Q1 | 266.35 Million AUD | 0.0% |
| 2013 Q3 | 360.1 Million AUD | 0.0% |
| 2013 Q4 | - AUD | -100.0% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 Q1 | 269.64 Million AUD | 0.0% |
| 2012 FY | 914.81 Million AUD | -6.2% |
| 2012 Q3 | 266.35 Million AUD | 0.0% |
| 2012 Q2 | 266.35 Million AUD | -1.22% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 FY | 975.24 Million AUD | 7.26% |
| 2011 Q3 | 269.64 Million AUD | 0.0% |
| 2011 Q2 | 269.64 Million AUD | -12.06% |
| 2011 Q1 | 306.62 Million AUD | 0.0% |
| 2010 FY | 909.25 Million AUD | 32.72% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q1 | 253.65 Million AUD | 0.0% |
| 2010 Q2 | 306.62 Million AUD | 20.88% |
| 2010 Q3 | 306.62 Million AUD | 0.0% |
| 2009 Q4 | - AUD | -100.0% |
| 2009 FY | 685.1 Million AUD | 16.76% |
| 2009 Q3 | 253.65 Million AUD | 0.0% |
| 2009 Q2 | 253.65 Million AUD | 34.37% |
| 2009 Q1 | 188.77 Million AUD | 0.0% |
| 2008 Q2 | 188.77 Million AUD | 11.34% |
| 2008 Q1 | 169.54 Million AUD | 0.0% |
| 2008 Q3 | 188.77 Million AUD | 0.0% |
| 2008 FY | 586.78 Million AUD | 26.79% |
| 2008 Q4 | - AUD | -100.0% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 FY | 462.78 Million AUD | 1490.44% |
| 2007 Q1 | 38.81 Million AUD | 0.0% |
| 2007 Q2 | 169.54 Million AUD | 336.76% |
| 2007 Q3 | 169.54 Million AUD | 0.0% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 FY | 29.09 Million AUD | -84.09% |
| 2006 Q2 | 38.81 Million AUD | -56.77% |
| 2006 Q3 | 38.81 Million AUD | 0.0% |
| 2006 Q1 | 89.78 Million AUD | 0.0% |
| 2005 FY | 182.85 Million AUD | 894.66% |
| 2005 Q1 | 39.07 Million AUD | 0.0% |
| 2005 Q4 | - AUD | -100.0% |
| 2005 Q3 | 89.78 Million AUD | 0.0% |
| 2005 Q2 | 89.78 Million AUD | 129.8% |
| 2004 Q1 | 31.44 Million AUD | 0.0% |
| 2004 Q2 | 39.07 Million AUD | 24.25% |
| 2004 Q3 | 39.07 Million AUD | 0.0% |
| 2004 Q4 | - AUD | -100.0% |
| 2004 FY | 18.38 Million AUD | -52.53% |
| 2003 Q3 | 31.44 Million AUD | 0.0% |
| 2003 Q2 | 31.44 Million AUD | -45.32% |
| 2003 Q1 | 57.5 Million AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 FY | 38.72 Million AUD | -41.15% |
| 2002 Q1 | 192.25 Million AUD | 0.0% |
| 2002 Q2 | 57.5 Million AUD | -70.09% |
| 2002 Q3 | 57.5 Million AUD | 0.0% |
| 2002 FY | 65.8 Million AUD | 262.02% |
| 2002 Q4 | - AUD | -100.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2001 Q1 | 33.82 Million AUD | 0.0% |
| 2001 Q2 | 192.25 Million AUD | 468.37% |
| 2001 Q3 | 192.25 Million AUD | 0.0% |
| 2001 FY | -40.61 Million AUD | -103.86% |
| 2000 Q2 | 33.82 Million AUD | 14.29% |
| 2000 Q1 | 29.59 Million AUD | 0.0% |
| 2000 Q4 | - AUD | -100.0% |
| 2000 Q3 | 33.82 Million AUD | 0.0% |
| 2000 FY | -19.92 Million AUD | -142.04% |
| 1999 Q4 | - AUD | -100.0% |
| 1999 Q1 | 27.6 Million AUD | 0.0% |
| 1999 Q2 | 29.59 Million AUD | 7.2% |
| 1999 Q3 | 29.59 Million AUD | 0.0% |
| 1999 FY | 47.39 Million AUD | 16.42% |
| 1998 FY | 40.71 Million AUD | -87.2% |
| 1998 Q4 | - AUD | -100.0% |
| 1998 Q3 | 27.6 Million AUD | 0.0% |
| 1998 Q2 | 27.6 Million AUD | -65.28% |
| 1998 Q1 | 79.52 Million AUD | 0.0% |
| 1997 Q2 | 79.52 Million AUD | 44.58% |
| 1997 Q4 | - AUD | -100.0% |
| 1997 Q1 | 55 Million AUD | 0.0% |
| 1997 Q3 | 79.52 Million AUD | 0.0% |
| 1997 FY | 318.09 Million AUD | 1476.26% |
| 1996 Q4 | 55 Million AUD | 0.0% |
| 1996 Q3 | 55 Million AUD | 0.0% |
| 1996 FY | -23.11 Million AUD | -20.96% |
| 1996 Q1 | 48.68 Million AUD | 0.0% |
| 1996 Q2 | 55 Million AUD | 12.98% |
| 1995 Q2 | 48.68 Million AUD | 23.43% |
| 1995 Q1 | 39.44 Million AUD | 0.0% |
| 1995 Q3 | 48.68 Million AUD | 0.0% |
| 1995 Q4 | 48.68 Million AUD | 0.0% |
| 1995 FY | -19.1 Million AUD | -153.71% |
| 1994 FY | -7.53 Million AUD | -5.21% |
| 1994 Q4 | 39.44 Million AUD | 0.0% |
| 1994 Q3 | 39.44 Million AUD | 0.0% |
| 1994 Q2 | 39.44 Million AUD | 25.09% |
| 1994 Q1 | 31.53 Million AUD | 0.0% |
| 1993 Q2 | 31.53 Million AUD | 0.0% |
| 1993 Q3 | 31.53 Million AUD | 0.0% |
| 1993 Q4 | 31.53 Million AUD | 0.0% |
| 1993 FY | -7.15 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 9.71 Million AUD | -58042.218% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | 387278.444% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 95236.517% |
| Biome Australia Limited | -1.91 Million AUD | 295380.53% |
| Patrys Limited | -3.53 Million AUD | 159726.611% |
| Orthocell Limited | -11.68 Million AUD | 48463.733% |
| Imugene Limited | -140.93 Million AUD | 4108.655% |
| Noxopharm Limited | -7.53 Million AUD | 75075.763% |
| PYC Therapeutics Limited | -38.85 Million AUD | 14638.931% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 45994.183% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 78712.533% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 78221.935% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 64240.266% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 78640.096% |
| Bio-Gene Technology Limited | -3.06 Million AUD | 184573.256% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | -11394.681% |
| Starpharma Holdings Limited | -15.15 Million AUD | 37367.796% |
| Nanollose Limited | -1.24 Million AUD | 452117.3% |
| Memphasys Limited | -2.7 Million AUD | 209028.447% |
| Invex Therapeutics Ltd | -2.13 Million AUD | 264880.358% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | 274802.669% |
| Amplia Therapeutics Limited | -4.42 Million AUD | 127771.434% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 38531.835% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | 196685.099% |
| Race Oncology Limited | -13.38 Million AUD | 42321.145% |
| Nyrada Inc. | -4.56 Million AUD | 123981.939% |
| Telix Pharmaceuticals Limited | - AUD | -Infinity% |
| Dimerix Limited | -25.05 Million AUD | 22643.788% |
| PharmAust Limited | -6.65 Million AUD | 84943.657% |
| Immutep Limited | -44.93 Million AUD | 12671.871% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 12710.139% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 28921.085% |
| BTC Health Limited | 1.05 Million AUD | -535244.908% |
| Acrux Limited | -9.83 Million AUD | 57547.887% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | -2400.166% |
| Biotron Limited | -5.15 Million AUD | 109772.661% |
| Tissue Repair Ltd | -4.87 Million AUD | 115963.043% |
| AdAlta Limited | -5.26 Million AUD | 107471.004% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 12066.62% |
| Hexima Limited | -1 Million AUD | 560142.153% |
| AnteoTech Limited | -11.72 Million AUD | 48276.141% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 8776.449% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 25719.535% |
| Avecho Biotechnology Limited | -4.58 Million AUD | 123202.91% |
| Actinogen Medical Limited | -12.83 Million AUD | 44102.097% |
| Immuron Limited | -5.8 Million AUD | 97485.111% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 99715.976% |